Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Identity and validity of conserved B cell epitopes of filovirus glycoprotein: towards rapid diagnostic testing for Ebola and possibly Marburg virus disease.

Babirye P, Musubika C, Kirimunda S, Downing R, Lutwama JJ, Mbidde EK, Weyer J, Paweska JT, Joloba ML, Wayengera M.

BMC Infect Dis. 2018 Oct 3;18(1):498. doi: 10.1186/s12879-018-3409-x.

2.

Evaluation of HIV-1 rapid tests and identification of alternative testing algorithms for use in Uganda.

Kaleebu P, Kitandwe PK, Lutalo T, Kigozi A, Watera C, Nanteza MB, Hughes P, Musinguzi J, Opio A, Downing R, Mbidde EK.

BMC Infect Dis. 2018 Feb 27;18(1):93. doi: 10.1186/s12879-018-3001-4.

3.

Successful Treatment of Human Plague with Oral Ciprofloxacin.

Apangu T, Griffith K, Abaru J, Candini G, Apio H, Okoth F, Okello R, Kaggwa J, Acayo S, Ezama G, Yockey B, Sexton C, Schriefer M, Mbidde EK, Mead P.

Emerg Infect Dis. 2017 Mar;23(3). doi: 10.3201/eid2303.161212.

4.

The Kynurenine Pathway of Tryptophan Catabolism and AIDS-Associated Kaposi Sarcoma in Africa.

Byakwaga H, Hunt PW, Laker-Oketta M, Glidden DV, Huang Y, Bwana BM, Mocello AR, Bennett J, Walusansa V, Dollard SC, Bangsberg DR, Mbidde EK, Martin JN.

J Acquir Immune Defic Syndr. 2015 Nov 1;70(3):296-303. doi: 10.1097/QAI.0000000000000747.

5.

Capacity for science in sub-Saharan Africa.

Elliott A, Nerima B, Bagaya B, Kambugu A, Joloba M, Cose S, Pantaleo G, Yazdanbakhsh M, Mabey D, Dunne D, Moffett A, Rwakishaya EK, Kaleebu P, Mbidde EK.

Lancet. 2015 Jun 20;385(9986):2435-7. doi: 10.1016/S0140-6736(15)61111-4. No abstract available.

PMID:
26122054
6.

Prevalence, incidence and risk factors for anogenital warts in Sub Saharan Africa: a systematic review and meta analysis.

Banura C, Mirembe FM, Orem J, Mbonye AK, Kasasa S, Mbidde EK.

Infect Agent Cancer. 2013 Jul 10;8(1):27. doi: 10.1186/1750-9378-8-27.

7.

Universal routine HPV vaccination for young girls in Uganda: a review of opportunities and potential obstacles.

Banura C, Mirembe FM, Katahoire AR, Namujju PB, Mbidde EK.

Infect Agent Cancer. 2012 Sep 5;7(1):24. doi: 10.1186/1750-9378-7-24.

8.

Clinical characteristics, treatment and outcome of childhood Burkitt's lymphoma at the Uganda Cancer Institute.

Orem J, Mulumba Y, Algeri S, Bellocco R, Mangen FW, Mbidde EK, Weiderpass E.

Trans R Soc Trop Med Hyg. 2011 Dec;105(12):717-26. doi: 10.1016/j.trstmh.2011.08.008. Epub 2011 Nov 1.

PMID:
22047912
9.

Risk of seropositivity to multiple oncogenic human papillomavirus types among human immunodeficiency virus-positive and -negative Ugandan women.

Namujju PB, Waterboer T, Banura C, Muwonge R, Mbidde EK, Byaruhanga R, Muwanga M, Surcel HM, Pawlita M, Lehtinen M.

J Gen Virol. 2011 Dec;92(Pt 12):2776-83. doi: 10.1099/vir.0.035923-0. Epub 2011 Aug 10.

PMID:
21832008
10.

Low avidity of human papillomavirus (HPV) type 16 antibodies is associated with increased risk of low-risk but not high-risk HPV type prevalence.

Namujju PB, Hedman L, Hedman K, Banura C, Mbidde EK, Kizito D, Byaruhanga RN, Muwanga M, Kirnbauer R, Surcel HM, Lehtinen M.

BMC Res Notes. 2011 Jun 6;4:170. doi: 10.1186/1756-0500-4-170.

11.

Type-specific incidence, clearance and predictors of cervical human papillomavirus infections (HPV) among young women: a prospective study in Uganda.

Banura C, Sandin S, van Doorn LJ, Quint W, Kleter B, Wabwire-Mangen F, Mbidde EK, Weiderpass E.

Infect Agent Cancer. 2010 Apr 9;5:7. doi: 10.1186/1750-9378-5-7.

12.

Risk of being seropositive for multiple human papillomavirus types among Finnish and Ugandan women.

Namujju PB, Surcel HM, Kirnbauer R, Kaasila M, Banura C, Byaruhanga R, Muwanga M, Mbidde EK, Koskela P, Lehtinen M.

Scand J Infect Dis. 2010 Jul;42(6-7):522-6. doi: 10.3109/00365540903582426.

PMID:
20180681
13.

Clinical characteristics and outcome of children with Burkitt lymphoma in Uganda according to HIV infection.

Orem J, Maganda A, Mbidde EK, Weiderpass E.

Pediatr Blood Cancer. 2009 Apr;52(4):455-8. doi: 10.1002/pbc.21769.

PMID:
18802952
14.

Prevalence, incidence and clearance of human papillomavirus infection among young primiparous pregnant women in Kampala, Uganda.

Banura C, Franceschi S, van Doorn LJ, Arslan A, Kleter B, Wabwire-Mangen F, Mbidde EK, Quint W, Weiderpass E.

Int J Cancer. 2008 Nov 1;123(9):2180-7. doi: 10.1002/ijc.23762.

15.

Current investigations and treatment of Burkitt's lymphoma in Africa.

Orem J, Mbidde EK, Weiderpass E.

Trop Doct. 2008 Jan;38(1):7-11. doi: 10.1258/td.2007.060093. Review.

PMID:
18302850
16.

Infection with human papillomavirus and HIV among young women in Kampala, Uganda.

Banura C, Franceschi S, Doorn LJ, Arslan A, Wabwire-Mangen F, Mbidde EK, Quint W, Weiderpass E.

J Infect Dis. 2008 Feb 15;197(4):555-62. doi: 10.1086/526792.

PMID:
18237268
17.

Detection of cervical human papillomavirus infection in filter paper samples: a comparative study.

Banura C, Franceschi S, van Doorn LJ, Wabwire-Mangen F, Mbidde EK, Weiderpass E.

J Med Microbiol. 2008 Feb;57(Pt 2):253-5. doi: 10.1099/jmm.0.47520-0. No abstract available.

PMID:
18201998
18.

Burkitt's lymphoma in Africa, a review of the epidemiology and etiology.

Orem J, Mbidde EK, Lambert B, de Sanjose S, Weiderpass E.

Afr Health Sci. 2007 Sep;7(3):166-75. Review.

19.

Clearance of circulating Epstein-Barr virus DNA in children with acute malaria after antimalaria treatment.

Donati D, Espmark E, Kironde F, Mbidde EK, Kamya M, Lundkvist A, Wahlgren M, Bejarano MT, Falk KI.

J Infect Dis. 2006 Apr 1;193(7):971-7. Epub 2006 Mar 1.

PMID:
16518759
20.
21.

Potential benefit and limitations of a broad access to potent antiretroviral therapy in developing countries.

Kaufmann GR, Smith D, Bucher HC, Phanuphak P, Sendi PP, Mbidde EK, Cooper DA, Battegay M.

Expert Opin Investig Drugs. 2002 Sep;11(9):1303-13. Review.

PMID:
12225251
22.

In vitro activities of voriconazole, fluconazole, and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and Africa.

Pfaller MA, Zhang J, Messer SA, Brandt ME, Hajjeh RA, Jessup CJ, Tumberland M, Mbidde EK, Ghannoum MA.

Antimicrob Agents Chemother. 1999 Jan;43(1):169-71.

23.
24.

Ethics of placebo-controlled trials of zidovudine to prevent the perinatal transmission of HIV in the Third World.

Mbidde EK.

N Engl J Med. 1998 Mar 19;338(12):837; author reply 840-1. No abstract available.

PMID:
9508630
25.

Single-dose ampicillin/sulbactam versus ceftriaxone as treatment for uncomplicated gonorrhoea in a Ugandan STD clinic population with a high prevalence of PPNG infection.

Hellmann NS, Nsubuga PS, Baingana-Baingi DJ, Desmond-Hellmann SD, Mbidde EK, Granowitz CB, Sande MA.

J Trop Med Hyg. 1995 Apr;98(2):95-100.

PMID:
7714943
26.

The value of a clinical definition for epidemic KS in predicting HIV seropositivity in Africa.

Desmond-Hellmann SD, Mbidde EK, Kizito A, Hellmann NS, Ziegler JL.

J Acquir Immune Defic Syndr. 1991;4(7):647-51.

PMID:
2051304
27.

Treatment of advanced Hodgkin's disease with high dose melphalan and autologous bone marrow transplantation.

Russell JA, Selby PJ, Ruether BA, Mbidde EK, Ashley S, Zulian G, Berry J, Houwen B, Jones AR, Poon MC, et al.

Bone Marrow Transplant. 1989 Jul;4(4):425-9.

PMID:
2673463
28.

High dose BCNU chemotherapy with autologous bone marrow transplantation and full dose radiotherapy for grade IV astrocytoma.

Mbidde EK, Selby PJ, Perren TJ, Dearnaley DP, Whitton A, Ashley S, Workman P, Bloom HJ, McElwain TJ.

Br J Cancer. 1988 Dec;58(6):779-82.

29.

High-dose melphalan and autologous bone marrow transplant as treatment for refractory Hodgkin's disease.

Selby PJ, Mbidde EK, Maitland J, McElwain TJ.

J Clin Oncol. 1986 Apr;4(4):612. No abstract available.

PMID:
3514810
30.

Phase II trial of carboplatin (JM8) in treatment of patients with malignant mesothelioma.

Mbidde EK, Harland SJ, Calvert AH, Smith IE.

Cancer Chemother Pharmacol. 1986;18(3):284-5.

PMID:
3542270
31.

Amino (hydroxyethoxymethyl) purine: a new well-absorbed prodrug of acyclovir.

Selby P, Powles RL, Blake S, Stolle K, Mbidde EK, McElwain TJ, Hickmott E, Whiteman PD.

Lancet. 1984 Dec 22;2(8417-8418):1428-30.

PMID:
6151046
32.

Letter: Chemotherapy of Hodgkin's disease.

Olweny CL, Mbidde EK, Nkwocha J, Magrath I, Ziegler JL.

Lancet. 1974 Dec 7;2(7893):1397. No abstract available.

PMID:
4143364
33.

Treatment of Kaposi's sarcoma by combination of actinomycin-D, vincristine and imidazole carboxamide (nsc-45388): results of a randomized clinical trial.

Olweny CL, Toya T, Mbidde EK, Lwanga SK.

Int J Cancer. 1974 Nov 15;14(5):649-56. No abstract available.

PMID:
4617713

Supplemental Content

Loading ...
Support Center